Pengfei Li
- Molecular Biology top 5%
- Cancer Research top 5%
- Pharmacology top 2%
- Physiology top 5%
- Immunology top 10%
- Topics
- RNA modifications and cancer (15 papers)Glycosylation and Glycoproteins Research (15 papers)Cancer-related molecular mechanisms research (15 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Pengfei Li
143 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Biology 1.9k
- Cancer Research 440
- Pharmacology 380
- Physiology 380
- Immunology 378
Countries citing papers authored by Pengfei Li
This map shows the geographic impact of Pengfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Li more than expected).
Fields of papers citing papers by Pengfei Li
This network shows the impact of papers produced by Pengfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Li. The network helps show where Pengfei Li may publish in the future.
Co-authorship network of co-authors of Pengfei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Li. A scholar is included among the top collaborators of Pengfei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Li. Pengfei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 13 | |
| 13 | 7 | |
| 14 | 0 | |
| 15 | 6 | |
| 16 | 34 | |
| 17 | Research progress in the relationship between type 2 diabetes mellitus and intestinal florabreakdown → | 325 |
| 18 | 32 | |
| 19 | 3 | |
| 20 | 21 |
About Pengfei Li
Pengfei Li is a scholar working on Cancer Research, Molecular Biology and Pharmacology, having authored 157 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Glycosylation and Glycoproteins Research (15 papers) and Cancer-related molecular mechanisms research (15 papers). The work is most often cited by research in Biological Psychiatry (191 citations), Cancer Research (440 citations) and Molecular Biology (1.9k citations). Pengfei Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huanjie Shao, Xiaohui Yan, Qi Miao, Yihong Zhan, Min Wang, Ting Wang, Quantao Ma, Jingkang Wang, Chunguo Wang and Yaqi Li. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.